Immunovant Inc

NASDAQ:IMVT   12:04:56 AM EDT
31.78
-0.74 (-2.28%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Immunovant Inc Stock, NASDAQ:IMVT

320 West 37th Street, 6th floor, New York, New York 10018
United States of America
Phone: +1.917.580.3099
Number of Employees: 164

Description

Immunovant, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded in 2018 and is headquartered in New York, NY.